Characterising cytotoxicity and genotoxicity of chemotherapeutic agents (Etoposide and Vincristine) on TK6, a human lymphoblastoid cell line by Edermaniger, L.
The Plymouth Student Scientist, 2015, 8, (2), 6-28 
 
[6] 
 
 
Characterising cytotoxicity and genotoxicity of 
chemotherapeutic agents (Etoposide and 
Vincristine) on TK6, a human lymphoblastoid 
cell line 
 
Leanne Edermaniger 
Project Advisor: Dr Craig Donaldson School of Biomedical & Biological Sciences, 
Plymouth University, Drake Circus, Plymouth, PL4 8AA 
 
Abstract 
The ability of the chemotherapeutic agents, namely etoposide and vincristine, to cause 
cytotoxic and genotoxic damage to the human lymphoblastoid cell line, TK6, was at the 
centre of this study. Four different cytotoxic assays were tested for their ability to assess the 
cytotoxicity of the agents as well as two genotoxic assays to examine their ability to induce 
DNA damage. The TK6 cell line was exposed to increasing doses of the chemotherapeutic 
agents and cytoxicity assessed by in vitro trypan blue, neutral red uptake, LDH leakage and 
the glucose oxidase assays. The trypan blue assay was deemed to be the most beneficial 
due to its ease and speed of quantifying the number of non-viable cells as through the loss 
of their membrane integrity they stain the characteristic blue colour. Genotoxicity on the 
other hand was measured by two assays; the micronucleus and Comet assays. Both are 
currently used within the laboratory setting but this study concluded the Comet assay was 
the best method for measuring DNA damage. Additionally, vincristine was found to be more 
cytotoxic than etoposide and also exerted further genotoxic effects upon the cells. Although 
only a pilot study, this work aimed to define the best cytotoxic and genotoxic detection 
methods using two widely used chemotherapeutic agents and show how they can impact 
upon cells and cancer/leukemic treatment regimens.   
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Introduction 
Extensive proliferation in mesenchymal and pluripotent stem cells is cited as the 
cause of haematological malignancies. Leukaemia accounts for 2.4% of all cancers 
in Europe; in 2008 there were 78,416 reported cases of lymphoid and/or myeloid 
forms of the disease (Visser et al., 2012). 
Chemotherapy has become a key intervention in the treatment of cancer and 
leukaemia. Generally, its use facilitates in the blocking or slowing down of cell growth. 
It works by targeting the cell cycle so any cell, diseased or healthy, in cell cycle at 
the time of administration will be affected. It is this which causes the side effects 
commonly associated with this form of intervention because the effects are seen 
where there is evidence of rapid cell proliferation such as the lining of GI tract and 
hair follicles hence hair loss, nausea and vomiting (Tolmack Sugerman, 2013). The 
use of haemopoietic stem cell transplantation is regarded as a possible life saving 
intervention for such diseases. However, the treatment requires the patient to 
undergo conditioning regimens which achieve total body irradiation thus reducing the 
risk of graft vs host disease and the activity of the malignancy itself (Gyurkcoza and 
Sandmaier, 2014). High dose chemotherapy regimens are myelosuppressive in that 
they irradiate the immune system to reduce the risk of relapse. However, although 
successful, such regimens display weaknesses such as increased risk of secondary 
malignancy. Noxious effects on the gastrointestinal, hepatic and pulmonary systems 
often result in death and in the case of children can affect growth and development 
(Gyurkcoza and Sandmaier, 2014). The increased toxicity associated with this form 
of regimen deems it inappropriate in the treatment of haematological malignancies in 
elderly patients. This is a fundamental issue as highlighted in a study by Puig et al., 
(2011) who stated that 20-44% of patients diagnosed with Hodgkin’s Lymphoma 
were above the age of 60.  Hence there is a need for a regimen which is not 
myeloablative, but could provide enough immunosuppression for successful 
transplantation in patients who are unable to tolerate the standard treatment 
(Bornhäuser et al., 2012). 
The use of reduced intensity conditioning (RIC) has had a fundamental impact upon 
the treatment of leukaemia, particularly for the use of allogeneic haemopoietic stem 
cell transplantation (Bornhäuser et al., 2012). Its use has allowed for the potential of 
allogeneic stem cell transplantation in elder patients and not just exclusively for 
younger patients, therefore becoming a curative method in the treatment of 
haematological cancers in patients who may have organ damage/dysfunction or who 
may have experienced complications during initial treatment as a result of infection 
(Bornhäuser et al., 2012). It is well documented that the transplantation of allogeneic 
stem cells is the gold standard in the treatment of many haematological diseases. 
However, due to the related toxicities of using high dose chemotherapy this was 
restricted to patients who were considered to be medically fit; those who were largely 
below the age of 55 (Schmid et al., 2006). That was until the introduction of reduced 
intensity conditioning which was not reliant on the patient being exposed to high 
doses and thus treatment related toxicities (Schmid et al., 2006). The risk of 
chemotherapy-induced toxicity increases with the presence of comorbidities linked to 
increasing age as well as physiological changes occurring within the body (Shayne 
et al., 2007). The foundation for using RIC was to give a therapeutic regimen which 
provides adequate immunosuppression in the patient in order to attain engraftment 
of donor cells, allowing these cells to recover haematopoietically and finally to 
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achieve a graft versus leukemic status (Ringdén et al., 2013). However, relapses of 
the disease are the most common cause of failure of stem cell transplant which 
accounts for around 33% of deaths after transplantation (Barrett, 2008). Although 
many of the side effects of chemotherapy such as hair loss, nausea and vomiting are 
expected and also reversible, patients are facing more long term complications such 
as secondary malignancies (Morgan and Rubin, 1998). This was also true in the 
Intergroupe Francophone du Myélome trial which was ended in 2011 due to patients 
with multiple myeloma who were treated with Lenalidomide had a higher significance 
of secondary malignancies compared to patients treated with a placebo (Fenk et al., 
2012). Alkylating agents and topoisomerase II inhibitors are known to increase the 
susceptibility of secondary malignancies. Leukaemia arising from treatment with 
alkylating agents tends to have a prolonged period of inactivity of around five years. 
However, patients exposed to topoisomerase II inhibitors can have a latency period 
which is significantly lower, approximately two years and the leukaemia can 
demonstrate cytogenetic abnormalities (Seiter et al., 2001). The incidence of 
secondary leukaemia is compared to the general population. Therefore, as these 
patients have already had exposure to a previous malignancy the incidence will be 
increased particularly as the general population won’t have had any previous 
exposure (Hasegawa et al., 2005). A study by Hasegawa et al., (2005) corroborates 
that recipients of bone marrow transplants are at a greater risk of secondary 
malignancy and this association is not reduced over time. The peak occurrence of a 
secondary malignancy following bone marrow transplant with a total body irradiation 
chemotherapy regimen is seven years however even after a median follow up of 11 
years the risk was still high. As well as this the majority of secondary malignancy 
occurred within the older population verifying age as a predisposing factor 
(Hasegawa et al., 2005).    
Generally chemotherapeutic agents are given in combinations in order to exploit their 
effects synergistically. This can be achieved by including chemotherapeutic agents 
which have distinct modes of action within the combination. This therefore poses 
challenges in the assessment of individual agents and their therapeutic effects. 
However, a study by May et al (2012) looked at the toxicity of chemotherapeutic 
agents and their damage to mesenchymal stem cells (MSC) as well developing a 
suitable in vitro model to assess the agent’s toxicology. The novel in vitro model 
devised by May et al., (2012) allows the cytotoxicity of a chemotherapeutic agent to 
be analysed on a different type of cell i.e. MSC. Moreover, the models resemblance 
of the in vitro situation is useful particularly as the limitations experienced when using 
animal models such as misjudging the toxic effect of a specific agent due to inter-
species differences can mean potentially effective drugs are disregarded for further 
testing as a result of the effect they have on an animal model (May et al, 2012).  
The toxic effects of two chemotherapeutic agents namely etoposide and vincristine 
are being assessed through the application of four cytotoxicity assays and two 
genotoxicity assays. The TK6 cells will be exposed to a reducing dose of each agent 
in all of the assays but the genotoxicity assays will focus on a low dose and a 
physiologically relevant concentration in comparison to an untreated control. 
Vincristine is a vinca alkaloid which is extracted from the plant Vinca rosea and has 
been in use as a cytotoxic agent for the treatment of cancer since 1962. It’s still in 
use today for a variety of haematological and solid malignancies. Its mechanism of 
action is through binding to tubulin dimers which in turn inhibits the formation of 
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microtubules and mitotic spindles. Ultimately this leads to apoptosis as mitosis is 
arrested in metaphase and thus the cells are unable to divide (Moore and Pinkerton, 
2009). Vincristine is metabolised in the liver to metabolites with a reduced activity 
which supports eventual excretion. This metabolism is carried out by the enzymes 
CYP 3A4 and 3A5 (Moore and Pinkerton, 2009).   
Etoposide on the other hand is a topoisomerase inhibitor derived from the plant 
alkaloid podophyllotoxin. These agents modify the structure of DNA by forming a 
cleavage complex, it is this DNA break which is taken advantage of in these anti-
cancer drugs as it prevents the re-ligation of the DNA strands causing apoptosis (Wu 
et al., 2011). Type II topoisomerases create a cleavage complex and passage 
through this and the subsequent resealing alters the shape of DNA. However, if 
religation fails to occur cell death can result. This is the process which anti-cancer 
drugs such as etoposide exploit by increasing the number of cleavage complexes 
and stimulating the development to cytotoxic lesions in the DNA thus promoting cell 
death (Wu et al., 2011). 
The rationale for using four cytotoxicity tests and two genotoxicity assays is due to 
the fact that each one measures toxicity in different ways. The use of cytotoxic 
assays has become an important aspect of explaining the toxicity of agents as well 
as monitoring both harmful and beneficial effects an agent may have on human cells. 
There are a number of different assays which can be employed to assess 
cytotoxicity. All of them have their advantages and disadvantages but the aim of this 
study is to establish the most suitable assay to use in a more extensive study.  One 
of the most common ways of measuring cytotoxicity is through viability assays. The 
viability assay used in this study was trypan blue. This type of assay is non-specific 
and is successful in staining dead/non-viable tissues or cells a characteristic dark 
blue colour. The method by which trypan blue works is the dye itself is negatively 
charged and only if a particular cells membrane is damaged does it interfere with it. 
This therefore means that any viable cells will not take up the trypan blue because 
the membrane of a cell is particular about which substances can pass through. Live 
cells also have efflux pumps at work which will prevent the dye getting into the cell 
by pushing out any dye managing to enter the cell (Tran et al. 2011). To contrast the 
trypan blue stain, a neutral red assay was also undertaken. However this is an 
uptake assay where the red dye is taken up by the lysosomes of undamaged cells, 
thus the more red dye which is read the more viable cells are present (Kura et al, 
2014). As well as this the use of a lactate dehydrogenase assay where the release of 
intracellular enzymes is measured has been utilised in a number of studies (Ivanova 
and Uhlig, 2008). This release of proteins/enzymes is known as a leakage assay 
because when cells are exposed to cytotoxic agents their membranes can lose their 
integrity causing the release, in this case of LDH into medium surrounding the cells. 
Therefore, the discharging of LDH into the medium is a sign of cell death as a result 
of the membranous damage caused by the cytotoxic agents the cell has been 
exposed to. This assay in particular is renowned for its simple assessment (Fotakis 
and Timbrell, 2006). The glucose assay is another way of measuring cytotoxicity. 
The culture medium in this assay includes glucose which is needed for cells to 
metabolise and develop. There is evidence that leukemic cells have an increase in 
glucose utilisation in order to maintain energy homeostasis in the cellular 
environment and resist apoptosis sustaining progression of the disease 
(Shanmugam et al., 2009). 
The Plymouth Student Scientist, 2015, 8, (2), 6-28 
 
[10] 
 
To test genotoxic effects two different methods have been employed; the comet 
assay and the micronucleus assay. The comet assay is also known as single-cell gel 
electrophoresis (SCGE) and is a technique used to detect damage to DNA in 
particular single strand breaks (SSB) and alkali-labile sites (ALS). This is calculated 
by the analysis of the migration of cleaved DNA following contact with an 
electrophoretic current from the nuclei of the cell. It is this migrating DNA which 
forms the comet tail (Guillamet et al. 2008). The use of Triton-x in the assay lyses 
the cells, releasing the soluble contents of the cell and eradicating both cellular and 
nuclear membranes. The bodies become embedded in agarose gel and form what 
are known as nucleoids due to their resemblance to nuclei. During the process of an 
electrophoretic field being forced on the cells if a DNA strand break occurs in a loop 
of DNA then it can stretch in the direction of the anode. Hence if there are further 
strand breaks then more DNA can migrate towards the anode and so more DNA will 
be in the comet tail (Azqueta and Collins, 2013). The micronucleus assay however 
measures genotoxic effects because it is able to expose both clastogenic and 
aneugenic effects. It is a popular assay due to its simplicity as well as being 
applicable to a wide range of different cells (Kirsch-Volders, 2011).  
Each test has its own advantages and disadvantages and by comparing all of the 
tests it will be possible to decide on which assay would be the most suitable to use if 
this was to become a more extensive investigative study. Particularly as this is only a 
pilot study. As well as this, the study will help to establish whether cells which are 
exposed to a reduce dosage of chemotherapeutic agents can survive with genotoxic 
damage. 
Methods 
Unless otherwise stated all reagents were sourced from Sigma-Aldrich, Dorset, UK. 
TK6 culture 
TK6 cells were seeded in vented culture flasks at a density of approximately 3 x 106 
per flask in 10ml TK6 medium (45ml of RPMI, 5ml foetal calf serum, 0.5ml 
penicillin/streptomycin and 0.5ml L-glutamine). Primary cultures were incubated at 
37oC in 5% CO2. Cells were then passaged every two days and reseeded at a 
density of 3 x 106.  
Chemotherapeutic agent cultures 
At the 7th passage, TK6 cells were seeded in a CellStar 12 well suspension culture 
plate at a concentration of 5 x 105 cells per well. The cytotoxicity assays were 
performed using different concentrations of the agents (for Etoposide; E5-20, E4-10, 
E3-5, E2-1 and E1-0.1µg/ml and for vincristine; V5-0.5, V4-0.1, V3-0.05, V2-0.01, 
V1-0.005µM) including the clinically relevant doses (E4 and V4). 5 x 105 cells were 
exposed to 1ml of each of the concentrations of chemotherapeutic agents to a 
corresponding well with an untreated control set up for each chemotherapeutic agent.  
The plate was then incubated (37oC/5% CO2) for 23 hours. 
Neutral red assay 
The supernatant was removed from the chemotherapeutic agents’ cultures and 
frozen for later use in the LDH and glucose assays. The tubes were split into 2 so 
duplicates could be performed. 5µl of triton X was added to the two control tubes (EC 
and VC). The cells were then washed in 1ml of PBS and 100µl of neutral red 
medium (5ml of PBS and 50µl of neutral red) was added to each tube. The tubes 
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were then incubated at 37oC for 2 hours. After the incubation period the neutral red 
medium was removed from the cells and they were subsequently washed in 150µl of 
PBS. 150µl of neutral red de-stain solution (10ml ethanol, 9.8ml distilled water and 
0.2ml glacial acetic acid) was added to each tube to elute the dye. Each tube was 
then placed into a 96 well plate along with 2 wells set up for just the de-stain solution. 
Neutral red absorption was detected at 450nm in a Versa Max micro plate reader. 
Trypan blue 
The trypan blue assay was performed with different concentrations of the agents as 
stated previously. 1ml of each of the concentrations was added to a corresponding 
well with an untreated control set up for each chemotherapeutic agent.  The plate 
was then incubated (37oC/5% CO2) for 20 hours.  
The different cell concentrations were independently mixed with trypan blue at a ratio 
of 1:1 and a total cell count was recorded for each drug at each concentration as well 
as a viable (unstained) cell count using a haemocytometer.  
LDH assay 
The cytotoxicity induced by etoposide and vincristine was also measured using the 
LDH assay. 10µl of thawed supernatant (previously frozen from the harvest prior to 
the trypan blue and neutral red assays) was then added to their own wells for each 
drug at each concentration in duplicate. To each of the wells containing the 
supernatant 40µl of 0.75mM sodium pyruvate/β-NADH solution was added but not to 
the standard wells and the plate was incubated at 37oC for 30 minutes. From here 
50µl of 2.4-dinitrophenylhydrazine was added to all wells including the standards and 
left at room temperature for 20 minutes. From here 50µl of 4M NaOH was added to 
all wells and a final colour allowed to develop until the absorbance was read at 
540nm on a Versa Max micro plate reader. A standard curve was produced from the 
pyruvate/β-NADH standards. 
Glucose assay 
Cellular toxicity can be measured through the concentration of glucose in culture 
media. For example if there is a decrease in the uptake of glucose then this is an 
indication of a reduction in the cells metabolism (May et al., 2012). A glucose assay 
was performed to assess glucose consumption by TK6 cells using a glucose oxidase 
kit adopting a 96 well plate format. Following the harvest of cells exposed to the 
various doses of etoposide and vincristine before the trypan blue and neutral red 
assays the supernatant was collected and frozen from each until required for 
analysis. To a Cell star cell solution 96 well plate, 10µl of sample or standard were 
added in duplicate as well as 100µl of glucose oxidase/peroxidase reagent. A 
standard curve was produced by making glucose standards of 0.02, 0.04, 0.08, 0.12, 
0.16 and 0.20 mg/ml. 100µl in duplicate was added to two empty wells of the well 
plate to serve as the reagent blank. To the plate standard or sample, 10µl was added 
in duplicate followed by 100µl of the assay reagent. The plate was then incubated at 
37oC for a total of 30 minutes. Immediately after removing from the incubator the 
absorbance was read at 450nm using a Versa Max micro plate reader.  
Alkaline comet assay 
The comet and micronucleus assays were assessed following cultures with the 
clinically relevant and lowest doses of etoposide (10µM and 0.1µM respectively) and 
vincristine (0.1µM and 0.005µM). 
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The comet assay was performed using TK6 cells (approximately 50000 cells in 20-
30µl) and re-suspended in 200µl of 0.5% low melting agarose (LMA) and pipetted 
onto pre-coated microscope slides. The slides were pre-coated in 1% normal melt 
agarose (NMA). After layering the cells in agarose on the slides a coverslip was 
placed on top and the agarose was left to solidify at room temperature for 30 minutes. 
The coverslips were then removed and the slides placed into pre-cooled lysis 
solution (NaCl, Na2 EDTA, Tris, 10% DMSO and 2% Triton-X) at room temperature 
for 1 hour in a foil covered coplin jar to prevent UV damage. The slides were then 
placed in a horizontal gel electrophoresis tank which was filled with pre-cooled 
electrophoresis buffer (20mM EDTA, 300mM NaOH, pH 13) for 20 minutes. This 
allowed the process of DNA unwinding to begin. Following this electrophoresis was 
performed at 0.7V/cm and 300mA in a cold cupboard for 20 minutes ensuring the 
slides were protected from light throughout. Once electrophoresis was performed the 
slides were neutralised twice in Tris at pH 7.5 with 10M HCl. The slides were then 
stored in a dark cupboard ready to be counted at a later date. 
Each slide was stained with 40µl of ethidium bromide (25 µg/ml) immediately before 
being analysed. The analysis of the slides was performed blind in that the slides had 
been coded to prevent bias. The slides were viewed under a Texas Red Filter with 
images collected containing 50-100 cells per treatment. The Perceptive Instruments 
Comet Assay IV software was used to measure DNA damage. 
Micronucleus assay 
The trypan blue assay was performed to determine how much culture was needed 
containing 20 000 cells. This volume for each concentration was re-suspended PBS 
making the volume up to 150µl. Each drug concentration was pipetted on a pre-
polished microscope slide and placed in a cytofunnel. The slides were centrifuged in 
a Thermoshandon Cytospin 4 (Runcorn, UK) at 1500rpm for 10 minutes. Once 
completed the slides were allowed to air dry until being fixed in 100% methanol for 8 
minutes. The slides were then stored until analysis could be performed. 
The following week the slides were analysed. For each slide 20µl of ethidium 
bromide was placed on the cytospin and a coverslip placed on top. The slides were 
analysed using a Leica epifluourescence microscope. 500-1000 cells per slide were 
analysed blind and a count of micronucleated (MN), apoptotic, blebbed, bi-nucleated 
and chromosomal cells was taken.  
Statistical analysis 
All values cited in the study signify Mean ± SD of the sample unless otherwise stated. 
All analyses were performed on raw data using SPSS 21. For trypan blue a one 
sample t-test was performed comparing viable cell numbers at each drug 
concentration with the control. For all other assays a one way ANOVA was 
performed followed by a post hoc Tukey test with each sample compared with the 
relevant control, p-Values below 0.05 were considered to be statistically significant. 
All graphs were produced in Microsoft Excel 2013. 
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Results 
Determining cell cytotoxicity 
Four different assays were used to measure the cytotoxicity of etoposide and 
vincristine on the TK6 cells. 
 
Figure 1. Testing cytotoxicity of etoposide and vincristine using the trypan blue assay. Cells 
were exposed to increasing doses of the chemotherapeutic agents as shown on the graph. 
The cell counts were performed in duplicate and the number of viable cells at each dose was 
calculated and plotted on the graph. The graph presents the two repeats for each 
chemotherapeutic agent. 
For the trypan blue assay in the case of the week one repeat there was a greater 
reduction in the number of viable cell numbers in the case of etoposide but there is 
also evidence that the untreated control had a considerably higher number of viable 
cells compared to the vincristine control (Fig. 1). However, due to the fact that there 
is an extensive range in counts a statistical analysis was unable to be performed to 
compare the repeats. For E2 a standard deviation ± 7.4 was produced, such a large 
SD would discredit the output of such an analysis. However, the week one results 
can be used to analyse the trend, in general as the chemotherapeutic agents dose 
increases as well as this a one sample t-test was performed for each of the week 
one counts in comparison with the relevant control. 
Neutral red 
The neutral red assay, however, is an uptake assay so is not looking at the number 
of viable cells but rather the uptake of the red dye by the cells: the higher the 
absorbance reading the higher the number or viable cells present. The reading for 
the control is in fact lower than that of the lowest dose of each of the agents. 
However, it does fall quite significantly in the case of etoposide more so than for 
vincristine (Fig. 2). 
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Figure 2. Testing the cytotoxicity of etoposide and vincristine using the uptake assay neutral 
red. 
A one way ANOVA with a post hoc Tukey test was performed for both agents. For 
vincristine there was no significance (p>0.05) but a p-value of 0.033 was obtained 
indicating significance between the groups. The Tukey test also gave a significant p-
value between E1 and E5 (0.029). 
Glucose concentration standard curve 
 
Figure 3. Glucose concentration in the supernatant gathered from TK6 cells exposed to 
increasing doses of etoposide and vincristine Graph represents Mean ±SD, n=2. 
The glucose concentration graph (Fig. 3) depicts the lowest concentration of glucose 
in the untreated controls as expected. However, the controls are considerably lower 
than the first dose particularly in the case of etoposide where there is a sharp rise in 
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glucose concentration. The highest concentration in both cases is seen in the 
highest doses of the chemotherapeutic agents. A one way ANOVA with a post hoc 
Tukey test was performed for etoposide and vincristine. Statistically significant p-
values were gathered for both agents 0.022 and 0.002 respectively.  
LDH standard curve 
 
Figure 4. Lactate dehydrogenase (LDH) activity determined from TK6 cells exposed to the 
increasing doses of etoposide and vincristine. Graph represents Mean ±SD, n=2. 
Figure 4, on the other hand, shows the LDH activity of the two different agents 
plateau along the increasing concentrations more so in the case of etoposide. A one 
way ANOVA was performed for both chemotherapeutic agents and in both cases 
there was no statistical significance identified. 
Determining cell genotoxicity using the micronucleus and Comet assays 
The genotoxic effects of etoposide and vincristine can be visualised in the 
micronucleus assay with a tally of the various characteristics seen at each of the 
doses; control, lowest dose (E1 and V1) and the clinically relevant dose (E4 and V4) 
as shown in table 1. When compared with the control each vincristine dose in the 
case of micronucleated cells has higher values yet apoptotic cells are notably lower 
than the control in E1, E4 and V1. As well as this V1 displayed a great number of 
chromosomal cells over a third of the total cells on the slide. Photographs were taken 
as shown in figure 5 showing the characteristic features highlighted in table 1 
alongside images from the control portraying normal cellular features. 
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Figure 5. Morphology of TK6 cells exposed to etoposide and vincristine at low dose and a 
clinically relevant dose. Normal cell morphology (A) but apoptotic cells can also be seen. (B) 
shows cells which have been exposed to 0.1µM of etoposide. A cell undergoing apoptosis 
(C) having been exposed to 10µM of etoposide. An example of a blebbed cell is visible. 
Cells exposed to 0.005µM of vincristine appeared to have chromosomal aberrations as 
depicted in (D) there is also a presence of 2 micronuclei and a blebbed cell (F) also shows 
this and micronuclei can clearly be seen. 
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E 
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Figure 6. Generic images taken from the Alkaline Comet Assay. (A) Control no tail. (B) V4 
with moderate tail. (C) E4 with extensive tail. (D) V4 with a moderate tail. 
 
Table 1. Quantity of different cell characteristics seen in the micronucleus assay with TK6 
cells exposed to an increase in drug concentration. Each sample contained 1000 cells. In 
both drugs an increase in micronucleated and apoptotic cells is seen when the dose is 
increased from the lowest to the clinically relevant. 
Dose Micronucleated Blebbed Apoptotic Binucleated Bridge 
bleb 
Chromosomal 
Control 15 25 40 10 5 0 
E1 5 5 15 5 0 0 
E4 10 10 25 15 0 0 
V1 40 4 16 4 0 380 
V4 48 0 48 32 0 0 
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Comet assay1 
 
 
 
 
 
 
 
 
 
 
Figure 7. Boxplot of tail length from the alkaline comet assay. Mean tail length appear to be 
similar for all of the chemotherapeutic agents in comparison with the control. There is a 
bigger range of length in the comet tail in the control as depicted in the upper quartile. A one 
way ANOVA was performed etoposide (p>0.05) and vincristine (p<0.05). 
 
In the case of tail length at both of the higher doses there is an increase in median 
tail length in comparison to the relevant lower doses and control. 
 
Figure 8. DNA damage in the control and the treated samples was assessed by the Comet 
assay and exemplified by % tail DNA. For etoposide (p<0.05) and vincristine (p>0.05) 
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Discussion 
The assessment of cytotoxicity is important when testing for genotoxicity. 
Cytotoxicity allows for the maximum concentration of a chemotherapeutic agent to 
be defined and through genotoxicity testing its capability of causing DNA damage 
(Shi et al., 2010).  
In this study trypan blue was the only cytotoxic assay which could determine the 
exact number of viable cells as the neutral red is an uptake assay and both LDH and 
glucose relied upon the assessment of the supernatant. The trypan blue viability 
assay is based upon the notion that viable cells do not lose their membrane integrity 
thus do not take up the dye whereas dead cells do stain blue (Strober, 1997). 
Apoptosis and necrosis are elements which can be responsible for the loss of a cells 
viability yet during the initial stages of apoptosis a cell may only be seen to possess 
an irregular membrane (Peter, 2011). For this assay it is expected that as the clinical 
doses of the chemotherapeutic agents increase, a decrease should be noticed in the 
number of viable TK6 cells. Figure 1 is a graphical representation of the number of 
viable cells in comparison to the doses of the chemotherapeutic agents. In the case 
of etoposide it is visible that there is a high number of viable cells present in the 
untreated control in that the lowest dose contains almost half the number of viable 
cells. The viable cell counts for each chemotherapeutic agent confirmed significantly 
reduced numbers in the presence of high etoposide or high vincristine doses (both 
p<0.05) from week one data confirming that when exposed to increasing doses of 
the chemotherapeutic agents cytotoxic effects occur. The results obtained for the 
second week are unreliable which could be due to a variety of reasons. The trypan 
blue stain can become toxic to cells over a prolonged period of time which could 
provide false positive results (Mascotti et al., 2000). In addition to this, trypan blue 
also doesn’t detect apoptotic cells which can give a false negative result with regards 
to total cell viability (Goktas et al., 2014). Figure 1 also shows that vincristine is more 
cytotoxic than etoposide due to the decreased number of viable cells compared to 
the numbers seen in etoposide. 
Neutral red is an alternative cytotoxic assay used to assess cell viability. This occurs 
through the cells uptake of the supravital dye and consequent build up in the 
lysosomes (Weyermann et al., 2005). The amount of dye which is held is directly 
proportional to the number of viable cells. The actual uptake of the dye relies upon 
the cells ability to sustain pH gradients, occurring through ATP synthesis. Therefore, 
in the case of cell death or if there is a reduction in the pH gradient then the cell is 
unable to take up the neutral red dye (Repetto et al., 2008). It is considered to have 
a good sensitivity in the analysis of viability and due to the assay time being less 
than a few hours is relatively quick in its determination of cytotoxicity (Ciapetti et al., 
1996). Yet in comparison to the trypan blue assay the neutral red uptake assay is 
considerably more time consuming. The assay itself requires few wash steps which 
contributes to its rapidity but the assay relies upon human efficiency in order to 
obtain accurate results (van Tonder et al., 2015). The results from this study can 
reflect this as seen in figure 2, where the absorbance of neutral red at the increasing 
doses of the agents, etoposide and vincristine varies rather than displaying a 
decrease in viability as the dose increases. This could be due to a number of 
reasons such as ensuring the cells were effectively washed in order to remove the 
neutral red medium (NRM) and the subsequent PBS which could potentially yield 
false positive results. Furthermore, the effects of the actions of chemotherapeutic 
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agents which occur are generally intracellular. Thus it is possible that the cells may 
already be committed to cell death or permanently damaged with an intact cell 
membrane making it possible for the cells to take up the neutral red dye yet they 
may actually be non-viable. This could therefore mean that such assays 
underestimate the damage to the cell again contributing to inaccurate results 
(Sumantran, 2011).  
Cancerous cells possess the ability to metabolically adapt resulting in changes to 
important cellular processes which can be detrimental in the progression of the 
disease. These processes can include the need for tightly regulated pH, varying 
degrees of hypoxia, high LDH levels and low glucose levels, all contribute to the 
cancer microenvironment and the advancement of the disease (Poder Anderson et 
al., 2013). 
It is widely publicised that the glycolytic rate of cancer cells is high through the 
increase of glucose uptake. This process is also known as the Warburg effect, first 
hypothesised by Otto Warburg in 1956 (Zhou et al., 2002). Acute lymphoblastic cells 
have been demonstrated to upregulate genes such as GLUT1 and GLUT4 which 
assist in glycolysis and thus contribute to an increased consumption of glucose 
(Shanmugam et al., 2009). Therefore, glucose has the vital role in the maintenance 
of the cells homeostasis with regards to its production of energy and also towards its 
survival thus resisting apoptosis (Shanmugam et al., 2009). However, a study by 
Zhou et al., (2002) describes that exposing cells to DNA damage inducing agents 
can cause genes involved in glucose metabolism to be down regulated resulting in 
the diminished utilisation of glucose. In this same study both etoposide and 
vincristine were used as DNA damaging agents and in both cases there was 
evidence of a reduction in both Glut-1 and Glut-3 protein levels.  
The purpose of the glucose assay was to determine the concentration of glucose 
remaining in the medium at each dose allowing the quantification of the metabolic 
activity of the cells exposed to increasing doses of etoposide and vincristine. 
Statistical significance was noted for both etoposide (p-0.022) and vincristine (p-
0.002) with a one way ANOVA with a post hoc Tukey test. For etoposide there were 
significant differences between doses compared to the control (p<0.05) except in the 
cases of E2, E3 and E4. There is a vast amount of scatter as illustrated by the error 
bars in figure 4 (Mean ±SD) particularly for E3. In the case of the control, untreated 
cells, it would be expected that these cells would have a high glucose consumption 
as they are proliferating and so less glucose in the culture media. Yet in the case of 
the high doses of etoposide and vincristine as the cells are exposed to considerably 
higher concentrations of the drug and thus should be undergoing apoptosis as a 
result, a higher level of glucose should be seen in the media. This is due to the fact 
that the cells will no longer require the glycolysis products needed to yield ATP as 
they are no longer proliferating due to their exposure to the cytotoxic agents 
(Israelsen and Vander Heiden, 2010). However, it is possible to see a decrease in 
the concentration of glucose left in the media at higher doses due to the fact that the 
TK6 cells will be actively trying to get rid of the drug and so will metabolise glucose in 
order to try to eliminate the drug itself. This can be explained through the mechanism 
of active efflux and drug transporters. Active efflux has become a major component 
in the disposition of agents and also their activity. To date approximately 20 varieties 
of drug transporter have been described all of which possess broad specificity for a 
number of pharmacologically separate compounds. This broad specificity is 
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accounted for by the fact the substrates are recognised in accordance with their 
chemical properties (van Bambeke, 2003). In the case of etoposide and vincristine 
the molecules associated with drug clearance from cells are multidrug resistance-
associated protein (MRP) and P-glycoprotein (P-gp). The latter is responsible for the 
catalysis of the outwards passage of chemotherapeutic agents which is dependent 
upon ATP (Naito et al., 1999).  
One of the most common parameters used in the study of cytotoxicity is the integrity 
of the cellular membrane. The lactate dehydrogenase assay (LDH) is an example of 
this as when cells become damage they release the stable enzyme into the 
surrounding media (Ivanova and Uhlig, 2008). The amount of enzyme activity is 
directly proportional to loss of membrane integrity/cell death thus supplying a precise 
measurement of cytotoxicity by a named agent (Sumantran, 2011). When cells are 
exposed to conditions which can render them unable to maintain homeostasis, an 
influx of water and ions occurs causing the cells organelles to swell and lyse. This 
compete rupture of the cell causes enzymes including lactate dehydrogenase to be 
released into the extracellular space. The quantification of the activity of such 
enzymes gives an indication to the amount of necrosis which has occurred (Miret et 
al., 2006). The LDH release assay has been described as being fast, reliable and is 
relatively easy to interpret (Fotakis and Timbrell, 2005). However, in this study the 
LDH assay produced no statistical significance for both etoposide and vincristine 
(p>0.05) when comparing the individual doses with the control. It is expected that at 
low concentrations of the chemotherapeutic agents the level of LDH activity in the 
medium will be low as the majority of the cells will be alive and proliferating. Yet in 
the higher doses it is anticipated that the agents would cause more damage to the 
cells which in turn would cause necrosis and damage to the cell membrane thus 
causing more LDH to escape into the culture media (Iliya and Wallace, 2011). This 
would also mean the lowest LDH activity should be within the control samples for 
each drug but figure 4 shows that the LDH activity of all of the chemotherapeutic 
agent doses are below the control with the exception of V3. A study by Pohjala et al., 
(2007) noticed that LDH was sub-optimal in determining the cytotoxic effects of 
agents which did not directly damage cell membranes. The study draws the 
conclusion that if the agent does not directly damage the cell membrane then it is 
able to retain its integrity until the latter stages of the cell death pathway. This could 
be a potential explanation in the plateau seen in figure 4 for the LDH activity of 
etoposide and in part for vincristine, as these agents are involved in DNA breakage 
and religation (Jacob et al., 2011) and depolymerising microtubules respectively 
(Moore and Pinkerton, 2009).  Another explanation may be human error particularly 
in pipetting technique can produce unanticipated results such as lower or higher 
readings thus adopting an efficient method or using calibrated pipettes and ensuring 
aliquots are correct should avoid this issue (Sigma-Aldrich, 2013). Not only this but 
2,4-dinitrophenylhydrazine is light sensitive which if exposed to UV could impact 
upon the final result (Miyoshi et al., 2006). 
In the case of the genotoxicity assays, the micronucleus assay (MN) is an in vitro 
analysis of aneugenicity and clastogenicity (Kimura, et al., 2013). In this study, MN 
was used to assess the genotoxic damage of etoposide at its lowest dose (0.1µM) 
and its physiologically relevant dose (10µM) and the same for vincristine, lowest 
(0.005µM) and physiologically relevant (0.5µM). Considering that the results 
obtained were only from one experiment and no repeats were carried out statistical 
analysis was not performed as it was unlikely to be valid. Instead table 1 shows the 
The Plymouth Student Scientist, 2015, 8, (2), 6-28 
 
[22] 
 
number of genetic features observed at the increasing doses in comparison with the 
control. Etoposide at its lowest dose induced 2/3 less micronuclei than the control 
and the physiologically relevant dose also didn’t exceed the number of micronuclei 
seen in the control but there was an increase between the two doses. There was 
also an increase in the number of apoptotic cells compared to the lower dose but 
again this was lower than the apoptotic cells counted in the control. However, 
vincristine on the other hand generated over double the number of MN in the lower 
dose and over three times the amount in comparison to the control at the 
physiologically relevant dose. Moreover, at the lowest dose of vincristine a 
considerable number of chromosomal aberrations were seen as shown in figure 6. 
However, none were recorded in the physiologically relevant dose yet the presence 
of chromosomal fragments was also noted in a study by Recio et al., (2010). They 
found that vincristine doesn’t induce DNA damage but did cause aneuploidy 
(chromosomal loss) through abnormal mitoses and micronuclei. Chromosomal 
material was noticed in the cells treated with vincristine which was likely to be 
complete chromosomes rather than fragments due to the aneugenic activity of the 
agent (Witt et al., 2007).  
The comet assay is used to assess an agent’s capability of inducing genotoxic 
damage (Shi et al., 2010). In the study the results produced were unreliable in that 
the cells for each of the chemotherapeutic agent doses were sparsely populated thus 
could not be used. There are a number of reasons why this may have happened 
such as the agarose gels coming off of the slides during the comet slide preparation 
as a result of the normal melt agarose not being heated to the right temperature. A 
further possibility is the temperature of low melting point agarose was too hot when 
the cover slips were applied (so not cooled sufficiently to 37oC) causing the cells to 
overflow to the extremities. However, previously collected results were used from 
another experiment and tail length and % tail DNA were analysed. % of tail DNA (tail 
intensity) was analysed as this is the preferred endpoint measure due to its ability to 
be compared across projects and its relation to DNA damage. In principle if a cell 
with 0% tail intensity is found this corresponds to no DNA damage likewise a positive 
increase in percentage indicates further DNA damage. Cells with a percentage 
greater than 85 represent dead or dying cells (Bright et al., 2011). From figure 7 it is 
visible that the control and both doses of vincristine have a range >85% thus 
indicating the presence of dead/dying cells. However the high proportion of DNA 
damage in the control could be a result of already necrotic cells thus already having 
DNA damage being taken into the assay. Prior to performing the Comet assay a cell 
count was performed using trypan blue on a 20µl aliquot of each dose. At each 
concentration a number of non-viable cells were recorded in the aliquot meaning 
already necrotic cells would be taken into the comet assay before DNA damage was 
assessed. This could also account for the increased tail length of the control in figure 
6. Etoposide constructs a ternary complex with DNA through the inhibition of 
topoisomerase II activity causing single and double strand breaks as it prevents the 
enzyme from religating (Wu et al., 2011). A study by Godard et al (1999) showed 
that etoposide caused DNA fragmentation but that it was possible that these cells 
were not in fact dead cells but that they did have stable ternary complexes. Moreover, 
a potential drawback of the assay itself is that it may produce bias results through 
cells being able to repair DNA damage in various phases of the cell cycle 
(Kruszewski et al., 2012). On the other hand, the comet assay is regarded as an 
adaptable and highly sensitive method to assess the genotoxic damage occurring in 
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cells and has been adapted over the last two decades to evaluate a range of DNA 
damage including both single and double strand breaks (Kruszewski et al., 2012). 
From carrying out these assays their relevance in the current field is noticeable 
particularly in the case of reduced intensity conditioning. This study has shown that 
lower doses of chemotherapeutic agents although cytotoxic can survive with 
genotoxic damage as seen with the lowest and clinically relevant dose of etoposide. 
Conclusion 
Overall, trypan blue and the Comet assay are the best cytotoxic and genotoxic 
assays if this was to become an investigative study. This is due to the rapidity and 
effectiveness including cost of the trypan blue assay to detect cytotoxicity by 
quantification of viable cells. As well as this, the comet assay has shown that 
vincristine is a more cytotoxic agent than etoposide but dose dependent increase in 
DNA damage was visible in the latter. Not only this but the comet assay can easily 
be performed subsequently after a trypan blue viability assay allowing the 
characterisation of cytotoxicity and genotoxicity of named agents to be prompt and 
effective. However, this was only a pilot study due to a lack of repeats, statistics and 
chemotherapeutic agents. Subsequent analyses would need to be undertaken to 
confirm the results obtained in this study. 
 
Acknowledgements 
The author would like to thank Dr Craig Donaldson for the guidance given throughout 
the project as well as Lynn Cooper and Will Vevers for technical assistance in the 
laboratory. In addition, thank you to Liana Gynn for sharing the Comet assay results 
and to Amisha Patel for sharing week 2 trypan blue and neutral red results. 
References 
Azqueta, A and Collins, A (2013). The Essential Comet Assay: A Comprehensive 
Guide to Measuring DNA Damage and Repair. Archives of Toxicology: 87 pp 949 – 
968.  
Barrett, A (2008). Understanding and Harnessing the Graft-Versus-Leukaemia Effect. 
British Journal of Haematology: 142 pp 877-888.  
Bornhäuser, M., Kienast, J., Trenschel, R., Burchert, A., Hegenbart, U., Stadler, M., 
Baurmann, H., Schäfer-Eckart, K., Holler, E., Kröger, N., Schmid, C., Einsele, H., 
Kiehl, M., Hiddermann, W., Schwerdtfeger, R., Buchholz, S., Dreger, P., Neubauer, 
A., Berdel, W., Ehninger, G., Beelen, D., Schetelig, J. and Stelljes, M (2012). 
Reduced-Intensity Conditioning Versus Standard Conditioning Before Allogeneic 
Haemopoietic Cell Transplantation in Patients with Acute Myeloid Leukaemia in First 
Complete Remission: A Prospective, Open Label Randomised Phase 3 Trial. Lancet 
Oncology: 13 pp 1035-44.  
Bright, J., Aylott, M., Bate, S., Geys, H., Jarvis, P., Saul, J. and Vonk, R. (2011). 
Recommendations on the Statistical Analysis of the Comet Assay. Pharmaceutical 
Statistics: 10 pp 485-493. 
The Plymouth Student Scientist, 2015, 8, (2), 6-28 
 
[24] 
 
Ciapetti, G., Granchi, D., Verri, E., Savarino, D., Cavedagna, D. and Pizzoferrato, A. 
(1996). Application of a Combination of Neutral Red and Amido Black Staining for 
Rapid, Reliable Cytotoxicity Testing of Biomaterials. Biomaterials: 17 pp 1259-1264. 
Doyle, N. (2008). Cancer Survivorship: Evolutionary Concept Analysis. Journal of 
Advanced Nursing: 62 pp 499-509. 
Fenk, R., Neubauer, F., Bruns, I., Schrӧder, T., Germing, U., Haas, R. and Kobbe, G. 
(2012). Secondary Primary Malignancies In Patients With Multiple Myeloma Treated 
With High-Dose Chemotherapy and Autologous Blood Stem Cell Transplantation. 
British Journal of Haematology: 156 pp 672 – 686. 
Fotakis, G. and Timbrell, J. (2006). In Vitro Cytotoxicity Assays: Comparison of LDH, 
Neutral Red, MTT and Protein Assay in Hepatoma Cell Lines Following Exposure to 
Cadmium Chloride. Toxicology Letters: 160 pp 171-177.  
Godard, T., Fessard, V., Huet, S., Mourot, A., Deslandes, E., Pottier, D., Hyrien, O., 
Sichel, F., Gauduchon, P. and Poul, J. (1999). Comparative In Vitro and In Vivo 
Assessment of Genotoxic Effects of Etoposide and Chlorothalonil by The Comet 
Assay. Mutation Research: 444 pp 103-116. 
Goktas, S., Sakarya, Y. and Sakarya, R. (2014). Trypan Blue Vital Dye Staining vs 
TUNEL Technique to Detect Corneal Endothelium Toxic Effects. JAMA: 132 pp 1491. 
Guillamet, E., Creus, A., Farina, M., Sabbioni, E., Fortaner, S. and Marcos, R. (2008). 
DNA-Damage Induction by Eight Metal Compounds in TK6 Human Lymphoblastoid 
Cells: Results Obtained with the Alkaline Comet Assay. Mutation Research: 654 pp 
22 – 28.  
Gyurkcoza, B. and Sandmaier, B. (2014). Conditioning Regimens for Hematopoietic 
Cell Transplantation: One Size Does Not Fit All. Blood: 124 pp 344-353.   
Hasegawa, W., Pond, G., Rifkind, J., Messner, H., Lau, A., Daly, A., Kiss, T., 
Kotchetkova, N., Galal, A. and Lipton, J. (2005). Long-Term Follow Up of Secondary 
Malignancies in Adults after Allogeneic Bone Marrow Transplantation. Bone Marrow 
Transplantation: 35 pp 51-55. 
Iliya, H. and Wallace, H. (2011). Cellular Growth Inhibition and Toxic Effects of 
Etoposide and Acetyl Salicyclic Acid. Nigerian Journal of Pharmaceutical Sciences: 
10 pp 57-64.  
Israelsen, W. and Vander Heiden, M. (2010). ATP Consumption Promotes Cancer 
Metabolism. Cell: 143 pp 669-671. 
Ivanova, L. and Uhlig, S. (2008). A Bioassay for the Simultaneous Measurement of 
Metabolic Activity, Membrane Integrity and Lysosomal Activity in Cell Cultures. 
Analytical Biochemistry: 379 pp 16-19.  
The Plymouth Student Scientist, 2015, 8, (2), 6-28 
 
[25] 
 
Jacob, D., Mercer, S., Osheroff, N. and Deweese, J. (2011). Etoposide Quinone Is a 
Redox-Dependent Topoisomerase II Poison. Biochemistry: 50 pp 5660-5667. 
Kimura, A., Miyata, A. and Honma, M. (2013). A combination of in vitro comet assay 
and micronucleus test using human lymphoblastoid TK6 cells. Mutagenesis: 23 pp 
583-590. 
Kirsch-Volders, M., Decordier, I., Elhajouji, A., Plas, G., Aardema, M. and Fenech, M. 
(2011). In vitro genotoxicity testing using the micronucleus assay in cell lines, human 
lymphocytes and 3D human skin models. Mutagenesis: 26 pp 177 – 184.  
Kruszewski, M., Iwaneko, T., Machaj, E., Oldak, T., Wojewodzka, M., Kapka-
Skrzypczak, l. and Pojda, Z. (2012). Direct Use of the Comet Assay To Study Cell 
Cycle Distribution and its Application to Study Cell Cycle-Dependent DNA Damage 
Formation. Mutagenesis: 27 551-558. 
Kura, A., Fakurazi, S., Hussein, M. and Arulselvan, A. (2014). Nanotechnology in 
Drug Delivery: The Need for More Cell Culture Based Studies in Screening. 
Chemistry Central Journal: 8 pp 1-7.  
Litzow, M. (2011). Pharmacotherapeutic Advances in the Treatment of Acute 
Lymphoblastic Leukaemia in Adults. Drugs: 71 pp415-442. 
Maddams, J., Utley, M. and Moller, H. (2012). Projections of Cancer Prevalence in 
the United Kingdom. British Journal of Cancer: 107 pp 1195-1202. 
Mascotti, K., McCullough, J. and Burger, S. (2000). HPC Viability Measurement: 
Trypan Blue versus Acridine Orange and Propidium Bromide. Transfusion:40 pp 
693-696. 
May, J., Morse, R., Xu, J. and Donaldson, C. (2012). Development of a Novel, 
Physiologically, Relevant Cytotoxicity Model: Application to the Study of 
Chemotherapeutic Damage to Mesenchymal Stromal Cells. Toxicology and Applied 
Pharmacology: 263 pp 374-389.  
Miret, S., Groene, E. and Klaffke, W. (2006). Comparison of In Vitro Assays of 
Cellular Toxicity in the Human Hepatic Cell Line HepG2. Journal of Biomolecular 
Screening pp 184-193. 
Moore, A. and Pinkerton, R. (2009). Vincristine: Can Its Therapeutic Index Be 
Enhanced? Pediatric Blood & Cancer: 53 pp 1180- 1187.  
Morgan, M. and Rubin, S. (1998). Long-Term Complications of Chemotherapy. 
Oncology Update: 5 pp 65-68. 
Myoshi, N., Oubrahim, H., Chock, B. and Stadtman, E. (2006). Age-Dependent Cell 
Death and the Role of ATP in Hydrogen Peroxide-Induced Apoptosis and Necrosis. 
PNAS: 103 pp 1727-1731. 
The Plymouth Student Scientist, 2015, 8, (2), 6-28 
 
[26] 
 
Naito, S., Yokomizo, A. and Koga, H. (1999). Mechanisms of Drug Resistance in 
Chemotherapy for Urogenital Carcinoma. International Journal of Urology: 6 pp 427-
439. 
Peter, M. (2011). Apoptosis Meets Necrosis. Nature: 471 pp 310-311.  
Poder Anderson, A., Moreira, J. and Pedersen, S. (2013). Interactions of Ion 
Transporters and Channels With Cancer Cell Metabolism and The Tumour 
Microenvironment. Philosophical Transactions of the Royal Society: 369 pp 1-11. 
Pohjala, L., Tammela, P., Samanta, S., Yli-Kauhaluoma, J. and Vuorela, P. (2007). 
Assessing the Data Quality in Predictive Toxicology Using a Panel of Cell Lines and 
Cytotoxicity Assays. Analytical Biochemistry: 362 pp 221-228. 
Puig, N., Pintilie, M., Seshadri, T., al-Farsi, K., Franke, N., Keating, A., Kuruvilla, J. 
and Crump, M. High-Dose Chemotherapy and Auto SCT in Elderly Patients with 
Hodgkin’s Lymphoma. Bone Marrow Transplantation: 46 pp 1339-1344. 
Recio, L., Hobbs, C., Caspary, W. and Witt, K. (2010). Dose-Response Assessment 
of Four Genotoxic Chemicals in a Combined Mouse and Rat Micronucleus (MN) and 
Comet Assay Protocol. The Journal of Toxicological Sciences: 35 pp 149-162. 
Repetto, G., del Peso, A. and Zurita, J. (2008). Neutral Red Uptake Assay for the 
Estimation of Cell Viability/Cytotoxicity. Nature: Protocols: 3 pp 1125-1131.  
Ringdén, O., Erkers, T., Aschan, J., Garming-Legert, K., Le Blanc, K., Hägglund, H., 
Omazic, B., Svenberg, P., Dahlöff, G., Mattsson, J., Ljungman, P. and Remberger, M. 
(2013). A Prospective Randomised Toxicity Study To Compare Reduced-Intensity 
and Myeloablative Conditioning in Patients with Myeloid Leukaemia Undergoing 
Allogeneic Haematopoietic Stem Cell Transplantation. Journal of Internal Medicine: 
274 pp 153-162.  
Schmid, C., Schleuning, M., Schwerdtfeger, R., Hertenstein, B., Mischak-Weissinger, 
E., Bunjes, D., Harsdorf, S., Scheid, C., Holtick, U., Greinix, H., Keil, F., Schneider, 
B., Sandherr, M., Bug, G., Tischer, J., Ledderose, G., Hallek, M., Hiddemann, W. 
and Kolb, H. (2006). Long-Term Survival in Refractory Acute Myeloid Leukaemia 
after Sequential Treatment with Chemotherapy and Reduced Intensity Conditioning 
for Allogeneic Stem Cell Transplantation. Blood: 108 pp 1092-1099.  
Seiter, K., Feldman, E., Sreekantaiah, C., Pozzuoli, M., Weisberger, J., Liu, D., 
Papageorgio, C., Weiss, M., Kancherla, R. and Ahmed, T. (2001). Secondary Acute 
Myelogenous Leukemia and Myelodysplasia without Abnormalities of Chromosome 
11q23 Following Treatment of Acute Leukemia with Topoisomerase II Based 
Chemotherapy. Leukaemia: 15 pp 963-970. 
The Plymouth Student Scientist, 2015, 8, (2), 6-28 
 
[27] 
 
Shanmugam, M., McBrayer, S. and Rosen, S. (2009). Targeting the Warburg Effect 
in Hematological Malignancies: From PET to Therapy. Current Opinion in Oncology: 
21 pp 531- 536.  
Shayne, M., Culakova, E., Poniewierski, M., Wolff, D., Dale, D., Crawford, J. and 
Lyman, G. (2007). Dose Intensity and Haematologic Toxicity in Older Cancer 
Patients Receiving Systemic Chemotherapy. Cancer: 110 pp 1611-1620. 
Shi, J., Springer, S. and Escobar, P. (2010). Coupling Cytotoxicity Biomarkers with 
DNA Damage Assessment in TK6 Human Lymphoblast Cells. Mutation Research: 
696 pp 167-178. 
Sigma-Aldrich (2013). Lactate Dehydrogenase Activity Assay Kit Technical Bulletin.  
Strober, W. (1997). Trypan Blue Exclusion Test of Cell Viability. Current Protocols in 
Immunology pp A3B.1-A3B.2. 
Sumantran, V. (2011). Cellular Chemosensitivity Assays: An Overview. Methods in 
Molecular Biology: 731 pp 219-236 
Tolmach Sugerman, B. (2013). Chemotherapy. The Journal of the American Medical 
Association: 310 pp 218.  
Tran, S., Puhar, A., Ngo-Camus, M. and Ramarao, N. (2011). Trypan Blue Dye 
Enters Viable Cells Incubated with the Pore-Forming Toxin HlyII of Bacillus Cereus. 
PLoS One: 6.   
Van Bambeke, F., Michot, J. and Tulkens, P. (2003). Antibiotic Efflux Pumps in 
Eukaryotic Cells: Occurrence and Impact on Antibiotic Cellular Pharmacokinetics, 
Pharmacodynamics and Toxicodynamics. Journal of Antimicrobial Chemotherapy: 
51 pp 1067-1077. 
Van Tonder, A., Joubert, A. and Cromarty, A. (2015). Limitations of the 3-(45-
dimethylthiazol-2-yl-2,5-diphenyl-2H-tetrazolium bromide (MTT) Assay When 
Compared to Three Commonly Used Cell Enumeration Assays. BMC Research 
Notes: 8 pp 1-10.  
Visser, O., Trama, A., Maynadié, M., Stiller, C., Marcos-Gragera, R., De Angelis, R., 
Mallone, S., Tereanu, C., Allemani, C., Ricardi, U. and Schouten, H. (2012). 
Incidence, Survival and Prevalence of Myeloid Malignancies in Europe. European 
Journal of Cancer: 48 pp 3257-3266. 
Weyermann, J., Lochmann, D. and Zimmer, A. (2005). A Practical Note on the Use 
of Cytotoxic Assays. International Journal of Pharmaceuticals: 288 pp 369-376. 
Wu, C., Li, T., Farh, L., Lin, L., Lin, T., Yu, Y., Yen, T., Chiang, C. and Chan, N. 
(2011). Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug 
Etoposide. Science: 333 pp 459- 462. 
The Plymouth Student Scientist, 2015, 8, (2), 6-28 
 
[28] 
 
Zhou, R., Vander Heiden, G. and Rudin, M. (2002). Genotoxic Exposure Is 
Associated with Alterations in Glucose Uptake and Metabolism. Cancer Research: 
62 pp 3515 – 3520.  
